These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11852940)

  • 1. Prescription discounts for health centers.
    Cauchi R; Hanson K
    NCSL Legisbrief; 2002 Jan; 10(5):1-2. PubMed ID: 11852940
    [No Abstract]   [Full Text] [Related]  

  • 2. West Virginia's Rx for drug costs: West Virginia's new prescription drug program is being called "the mouse that roared".
    Kent C
    State Legis; 2005 Feb; 32(2):23. PubMed ID: 15704275
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 4. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 5. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering Part D drug costs without direct CMS negotiations.
    Sipkoff M
    Manag Care; 2009 Sep; 18(9):11-2. PubMed ID: 19886203
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for managing prescription drug costs.
    Stern L
    Bus Health; 1990 Jun; 8(6):41-2, 44. PubMed ID: 10104793
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 11. States combat drug costs.
    Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
    [No Abstract]   [Full Text] [Related]  

  • 12. States on the Front Line: Addressing America's Drug Pricing Problem.
    Riley T; Lanford S
    J Leg Med; 2019; 39(2):81-93. PubMed ID: 31503529
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical price controls at the state level.
    Kozma CM
    Manag Care Interface; 2001 Jul; 14(7):59-60. PubMed ID: 11481818
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 17. Data watch. Is this the way to manage pharmacy costs?
    Bus Health; 1997 Sep; 15(9):94. PubMed ID: 10173238
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.